Posts

Showing posts with the label Viscosupplementation Market 2028

Viscosupplementation Market To Expand Industry Growth At USD 7.6 Billion By 2028

Image
  San Francisco, 5 Jan 2022:   The Report  Viscosupplementation Market  Size, Share & Trends Analysis Report By Product (Single, Three, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2021 - 2028 The global viscosupplementation market size is expected to reach USD 7.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 9.37% from 2021 to 2028. Initiatives to increase awareness regarding available treatment, the rising geriatric population, and product advancements are expected to boost market growth during the forecast period. With the growing geriatric population, the burden of osteoarthritis is expected to increase dramatically. As per the Arthritis Foundation, in the U.S., around 54.4 million adults are reported to be diagnosed with doctor-diagnosed arthritis. Favorable reimbursement policies with respect to the geriatric population are expec

Viscosupplementation Market To Expand Industry Growth At USD 7.6 Billion By 2028

Image
  San Francisco, 18 Oct 2021:   The Report  Viscosupplementation Market  Size, Share & Trends Analysis Report By Product (Single, Three, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2021 - 2028 The global viscosupplementation market size is expected to reach USD 7.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 9.37% from 2021 to 2028. Initiatives to increase awareness regarding available treatment, the rising geriatric population, and product advancements are expected to boost market growth during the forecast period. With the growing geriatric population, the burden of osteoarthritis is expected to increase dramatically. As per the Arthritis Foundation, in the U.S., around 54.4 million adults are reported to be diagnosed with doctor-diagnosed arthritis. Favorable reimbursement policies with respect to the geriatric population are expe